This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mediware Announces Results For Fiscal Fourth Quarter And Fiscal Year Ended June 30, 2012

LENEXA, Kan., Sept. 11, 2012 (GLOBE NEWSWIRE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW), a provider of comprehensive healthcare software solutions, today reported that revenues for the fourth quarter of the 2012 fiscal year, ended June 30, 2012, were $16.7 million, a four percent increase over the $16.0 million reported for the year ago quarter. Earnings per share for the fourth quarter rose to $0.29, compared to the $0.25 per share reported in the same period in fiscal 2011.

For the full year Mediware reported total revenue of $64.6 million, a 16 percent increase over the $55.5 million reported for the previous fiscal year. Earnings per share for the fiscal year were $0.90, a 17 percent increase over the $0.77 per share generated in fiscal 2011.

Commenting on the company's performance, president and CEO, Thomas Mann, said: "I'm pleased to report that we have continued to grow both revenue and earnings for the business on the strength of several of our products lines. Revenue for the year exceeded $64 million, producing a $0.90 EPS. These results were driven by several significant new contracts, ongoing work with the Department of Defense, and the continued effectiveness of our operational management programs."

Highlights for the quarter include:
  • Total revenue of $16.7 million.
  • Operating income increased 33 percent to $3.9 million, from $3.0 million in the year ago quarter.
  • Earnings per share increased to $0.29 from the $0.25 reported in the year ago quarter.

Highlights for full year include:
  • Total revenue of $64.6 million.
  • Operating income increased 25 percent to $11.1 million, from $8.9 million in the prior year.
  • Earnings per share increased to $0.90, from the $0.77 reported in the prior year.
  • Cash increased to $40.2 million.
Fiscal 2012 and 2011 
Quarterly Earnings Operating Statement Highlights
(in thousands):
  Quarter Ended June 30,
  2012 2011
Total Revenue $16,670 $15,976
Gross Profit $11,316 $10,527
Net Income  $2,463 $2,102
Earnings Per Diluted Share $0.29 $0.25
Fiscal 2012 and 2011 
Annual Operating Statement Highlights
(in thousands):
  Year Ended
  June 30,
  2012 2011
System Sales $17,620 $14,413
Services $46,981 $41,110
Total Revenue $64,601 $55,523
Operating Expenses $53,461 $46,583
Operating Income  $11,140 $8,940
Net Income  $7,545 $6,292
Earnings Per Diluted Share  $0.90 $0.77
Condensed Balance Sheet Highlights
(in thousands):
  Period Ended
  June 30,
  2012 2011
Cash and Cash Equivalents $40,155 $29,987
Working Capital $31,698 $24,745
Stockholders' Equity $64,131 $54,972

About Mediware

Mediware delivers interoperable, best-of-breed software systems that improve efficiencies and address safety concerns, enabling healthcare organizations to improve care processes while decreasing costs. Core Mediware solutions include blood management technologies for hospitals and blood centers; cell therapy solutions for cord blood banks, cancer treatment centers and research facilities; medication management solutions for hospitals, behavioral health facilities, infusion and specialty pharmacy providers; and business intelligence-based performance management solutions for clinical, regulatory and financial aspects of the broader healthcare market. For more information about Mediware products and services, visit our website at .

Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and are intended to be covered by the safe harbor created thereby. Such forward-looking statements are not necessarily based on historical facts and involve known and unknown risks, uncertainties and other factors which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward looking statements. These risks and uncertainties include but are not limited to those disclosed in the Company's Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. The Company does not intend to, and undertakes no obligation to, update forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results, financial condition or business over time. The Company regularly posts important information to the investor relations section of its website.
CONTACT: Bob Watkins

MEDIWARE Information Systems, Inc. Logo

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,836.52 +46.33 0.28%
S&P 500 1,987.51 +7.59 0.38%
NASDAQ 4,761.4710 +13.11 0.28%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs